China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
29.23
+0.10 (0.34%)
At close: Feb 6, 2026

SHA:600511 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
22,05425,81921,59421,05123,78937,205
Market Cap Growth
-3.12%19.57%2.58%-11.51%-36.06%80.69%
Enterprise Value
16,86720,03415,88916,87119,90234,465
Last Close Price
29.2333.3027.1425.9128.5543.93
PE Ratio
10.9712.9110.0610.7213.5626.91
Forward PE
10.4310.718.9110.0112.8719.84
PS Ratio
0.420.510.440.460.510.92
PB Ratio
1.111.361.231.331.662.84
P/TBV Ratio
1.251.551.411.531.933.39
P/FCF Ratio
38.8416.898.379.2912.7730.18
P/OCF Ratio
34.5415.567.928.7912.1528.58
PEG Ratio
5.212.372.372.372.372.37
EV/Sales Ratio
0.320.400.320.370.430.85
EV/EBITDA Ratio
7.589.056.396.969.2420.65
EV/EBIT Ratio
8.459.526.707.289.6922.01
EV/FCF Ratio
29.7013.116.167.4510.6927.96
Debt / Equity Ratio
0.030.050.030.030.050.06
Debt / EBITDA Ratio
0.290.360.210.210.310.46
Debt / FCF Ratio
1.150.550.210.230.380.65
Asset Turnover
1.501.501.601.581.761.65
Inventory Turnover
9.3110.5411.9011.5313.0511.63
Quick Ratio
1.771.681.731.711.631.68
Current Ratio
2.152.042.042.021.931.97
Return on Equity (ROE)
11.00%11.67%13.98%14.09%14.05%11.95%
Return on Assets (ROA)
3.59%3.90%4.78%5.03%4.85%3.99%
Return on Invested Capital (ROIC)
13.09%21.00%25.82%24.13%21.03%16.79%
Return on Capital Employed (ROCE)
9.50%10.50%12.80%13.70%13.50%11.50%
Earnings Yield
9.12%7.75%9.94%9.33%7.37%3.72%
FCF Yield
2.57%5.92%11.96%10.76%7.83%3.31%
Dividend Yield
2.74%2.40%3.15%3.02%2.45%1.25%
Payout Ratio
28.53%34.12%33.06%31.16%36.36%44.34%
Buyback Yield / Dilution
0.00%-0.00%0.00%0.00%-0.00%0.98%
Total Shareholder Return
2.75%2.40%3.15%3.02%2.45%2.23%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.